Retrospective analysis of topotecan administered weekly in heavily pretreated recurrent epithelial ovarian carcinoma patients.

被引：0
|
作者：
O'Malley, D [1 ]
Makkenchery, A [1 ]
Tangir, J [1 ]
Kelly, M [1 ]
Azodi, M [1 ]
Chambers, S [1 ]
Schwartz, P [1 ]
Rutherford, T [1 ]
机构：
[1] Yale Univ, Med Ctr, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5079
引用
收藏
页码：468S / 468S
页数：1
相关论文
共 50 条
  • [41] CLINICAL BENEFIT OF ORAL METRONOMIC CYCLOPHOSPHAMIDE ADMINISTRATION IN HEAVILY PRETREATED RECURRENT EPITHELIAL OVARIAN CANCER
    Attianese, D.
    Badellino, E.
    Villa, M.
    Bellero, M.
    Massobrio, R.
    Fuso, L.
    Biglia, N.
    Ferrero, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A230 - A230
  • [42] Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
    Martin, Jovana Y.
    Urban, Renata R.
    Liao, John B.
    Goff, Barbara A.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 27 (05)
  • [43] Pegylated liposomal doxorubicin (PLD) in heavily pretreated epithelial ovarian cancer patients
    Gorumlu, Gurbuz
    Kucukzeybek, Yuksel
    Karabulut, Bulent
    Terek, Mustafa C.
    Uslu, Ruchan
    Sanli, Ulus A.
    Akman, Levent
    Ozsaran, Aydin
    Dikmen, Yilmaz
    Goker, Erdem
    ANNALS OF ONCOLOGY, 2006, 17 : 172 - 172
  • [44] Phase II Study of Combination Chemotherapy with Etoposide and Ifosfamide in Patients with Heavily Pretreated Recurrent or Persistent Epithelial Ovarian Cancer
    Kang, Heeseok
    Kim, Tae-Joong
    Choi, Chel Hun
    Lee, Jeong-Won
    Lee, Je-Ho
    Bae, Duk-Soo
    Kim, Byoung-Gie
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (05) : 945 - 950
  • [45] Epithelial ovarian carcinoma in very young patients.
    Michels, Judith
    Caron, Olivier
    Rey, Annie
    Dunant, Ariane
    Duvillard, Pierre
    Gouy, Sebastien
    Leary, Alexandra
    Lhomme, Catherine
    Morice, Philippe
    Pautier, Patricia
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] A RETROSPECTIVE ANALYSIS OF IRINOTECAN FOR HEAVILY PRETREATED ESOPHAGEAL SQUAMOUS CELL CARCINOMA
    Fukushima, Ryoko
    Iwasa, Satoru
    Shoji, Hirokazu
    Okita, Natsuko
    Takashima, Atsuo
    Honma, Yoshitaka
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Shimada, Yasuhiro
    ANNALS OF ONCOLOGY, 2014, 25
  • [47] A phase II trial of weekly topotecan for patients with secondary platinum-resistant recurrent epithelial ovarian carcinoma following the failure of second-line therapy
    Spannuth, Whitney A.
    Leath, Charles A., III
    Huh, Warner K.
    Barnes, Mack N., III
    Davidson, Susan A.
    Kilgore, Larry C.
    Partridge, Edward E.
    Austin, J. Maxwell, Jr.
    Alvarez, Ronald D.
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : 591 - 595
  • [48] Phase I and pharmacological study of single paclitaxel administered weekly for heavily pre-treated patients with epithelial ovarian cancer
    Takano, M
    Kikuchi, Y
    Kita, T
    Suzuki, M
    Ohwada, M
    Yamamoto, T
    Yamamoto, K
    Inoue, H
    Shimizu, K
    ANTICANCER RESEARCH, 2002, 22 (03) : 1833 - 1838
  • [49] Outcome of heavily pretreated recurrent oral squamous cell carcinoma after salvage resection: A monocentric retrospective analysis
    Horn, Dominik
    Bodem, Jens
    Freudlsperger, Christian
    Zittel, Sven
    Weichert, Wilko
    Hoffmann, Jurgen
    Freier, Kolja
    JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2016, 44 (08) : 1061 - 1066
  • [50] THE EFFECT OF SINGLE WEEKLY PACLITAXEL IN HEAVILY PRETREATED OVARIAN CANCER PATIENTS AND ITS ANTIANGIOGENIC EFFECTS
    Kikuchi, Yoshihiro
    Kita, Tsunekazu
    Takano, Masashi
    Kudoh, Kazuya
    Saito, Keiko
    Fujii, Kazuyuki
    Sasaki, Naoki
    ANTICANCER RESEARCH, 2004, 24 (5D) : 3535 - 3535
12345